Hiraoka A - Search Results

1

[Clinical effects of cefodizime in severe infections complicated with hematological diseases. Hanshin Infection Study Group].

Teshima H, Masaoka T, Hiraoka A, Horiuchi A, Hasegawa H, Kitani T, Tagawa S, Yonezawa T, Kanayama Y, Take H, et al. Teshima H, et al. Among authors: hiraoka a. Jpn J Antibiot. 1992 Oct;45(10):1295-304. Jpn J Antibiot. 1992. PMID: 1479681 Japanese.

2

[Clinical evaluation of cefpirome sulfate for severe infections in patients with hematological disorders. Hanshin Study Group of Hematopoietic Disorders and Infections].

Hamazaki H, Hasegawa H, Horiuchi A, Teshima H, Hiraoka A, Masaoka T, Nasu K, Uchino H, Tatsumi N, Inoue N, Kageyama T, Kawagoe H, Tukaguchi M, Hukuhara S, Takahashi T, Takatsuka H, Kanamaru A, Kakishita E, Nagai K, Hara H, Kanayama Y, Sugiyama H, Kitani T. Hamazaki H, et al. Among authors: hiraoka a. Jpn J Antibiot. 1997 Jan;50(1):12-21. Jpn J Antibiot. 1997. PMID: 9059910 Clinical Trial. Japanese.

3

Clinical effect of BV-araU on varicella-zoster virus infection in immunocompromised patients with haematological malignancies.

Hiraoka A, Masaoka T, Nagai K, Horiuchi A, Kanamaru A, Niimura M, Hamada T, Takahashi M. Hiraoka A, et al. J Antimicrob Chemother. 1991 Mar;27(3):361-7. doi: 10.1093/jac/27.3.361. J Antimicrob Chemother. 1991. PMID: 1645332 Clinical Trial.

4

Clinical effect of granulocyte colony-stimulating factor on neutrophils and leukemic cells in myelogenous leukemia: analysis.

Ishikawa J, Yoshimura M, Matsunashi T, Tominaga N, Teshima H, Hiraoka A, Nakamura H, Shibata H, Masaoka T, Takaku F. Ishikawa J, et al. Among authors: hiraoka a. Jpn J Clin Oncol. 1991 Jun;21(3):169-75. Jpn J Clin Oncol. 1991. PMID: 1719259

5

[Early phase II study of MST-16 (sobuzoxane) on malignant lymphoma].

Tominaga N, Teshima H, Hiraoka A, Masaoka T, Ariyoshi Y, Suzuki H, Kimura I, Ohnoshi T, Hayashi K, Arima T, et al. Tominaga N, et al. Among authors: hiraoka a. Gan To Kagaku Ryoho. 1991 Nov;18(14):2441-6. Gan To Kagaku Ryoho. 1991. PMID: 1952963 Japanese.

6

[HLA-mismatched bone marrow transplantation].

Hiraoka A, Masaoka T. Hiraoka A, et al. Nihon Rinsho. 1990 Sep;48(9):1994-2002. Nihon Rinsho. 1990. PMID: 2232202 Japanese. No abstract available.

7

Clinical effects of recombinant human granulocyte colony-stimulating factor in leukemia patients: a phase I/II study.

Teshima H, Ishikawa J, Kitayama H, Yamagami T, Hiraoka A, Nakamura H, Shibata H, Masaoka T, Takaku F. Teshima H, et al. Among authors: hiraoka a. Exp Hematol. 1989 Sep;17(8):853-8. Exp Hematol. 1989. PMID: 2475358

8

Granulocyte colony-stimulating factor in allogeneic bone marrow transplantation.

Kitayama H, Ishikawa J, Yamagami T, Teshima H, Hiraoka A, Nakamura H, Shibata H, Masaoka T, Ishigami S, Takaku F. Kitayama H, et al. Among authors: hiraoka a. Jpn J Clin Oncol. 1989 Dec;19(4):367-72. Jpn J Clin Oncol. 1989. PMID: 2481758

9

A new nitrosourea derivative for the treatment of chronic myelogenous leukemia.

Hiraoka A, Masaoka T, Shibata H, Miyazaki T, Nakamura T, Yasunaga K, Kitani T, Yonezawa T, Kawagoe H, Horiuchi A, et al. Hiraoka A, et al. Leuk Res. 1988;12(6):487-90. doi: 10.1016/0145-2126(88)90115-4. Leuk Res. 1988. PMID: 3043111 Clinical Trial.

10

Hematological response to the new synthetic muramyl dipeptide derivative muroctasin after chemotherapy in patients with malignant lymphoma. A randomized crossover trial.

Hiraoka A, Masaoka T, Satoh T, Ota K, Oyama A, Horiuchi A, Hasegawa H, Nagai K, Kosaki M, Kanemaru A, et al. Hiraoka A, et al. Arzneimittelforschung. 1988 Oct;38(10):1499-501. Arzneimittelforschung. 1988. PMID: 3058133 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

603 results

Search Page

Filters